659
Views
3
CrossRef citations to date
0
Altmetric
Review

Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review

, &
Pages 173-184 | Published online: 01 May 2019

References

  • FreemanRWielingWAxelrodFBConsensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndromeClin Auton Res2011212697221431947
  • GoldsteinDSSharabiYNeurogenic orthostatic hypotension: a pathophysiological approachCirculation2009119113914619124673
  • IsaacsonSSkettiniJNeurogenic orthostatic hypotension in Parkinson’s disease: evaluation, management, and emerging role of droxidopaVasc Health Risk Manag20141016917624729712
  • IbrahimMMLocalization of lesion in patients with idiopathic orthostatic hypotensionBr Heart J19753788688721191448
  • MasakiKHSchatzIJBurchfielCMOrthostatic hypotension predicts mortality in elderly men: the Honolulu Heart programCirculation19989821229022959826316
  • EjazAAHaleyWEWasilukAMeschiaJFFitzpatrickPMCharacteristics of 100 consecutive patients presenting with orthostatic hypotensionMayo Clin Proc200479789089415244385
  • MagerkurthCSchnitzerRBrauneSSymptoms of autonomic failure in Parkinson’s disease: prevalence and impact on daily lifeClin Auton Res2005152768215834763
  • MerolaASawyerRPArtusiCAOrthostatic hypotension in Parkinson disease: impact on health care utilizationParkinsonism Relat Disord201847454929195729
  • ClaassenDOAdlerCHHewittLAGibbonsCCharacterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregiversBMC Neurol201818112530144800
  • BlumIBarkanAYeshurunDThyrotoxicosis presenting as orthostatic hypotensionPostgrad Med J1980566564254267413544
  • JohanssonMRicciFAungNSuttonRMelanderOFedorowskiAInflammatory biomarker profiling in classical orthostatic hypotension: insights from the SYSTEMA cohortInt J Cardiol201825919219729579600
  • LutherMSKrewerCMüllerFKoenigEOrthostatic circulatory disorders in early neurorehabilitation: a case report and management overviewBrain Inj200721776376717653950
  • GazitYNahirAMGrahameRJacobGDysautonomia in the joint hypermobility syndromeAm J Med20031151334012867232
  • ShenSHeTChuJHeJChenXUncontrolled hypertension and orthostatic hypotension in relation to standing balance in elderly hypertensive patientsClin Interv Aging20151089790626064042
  • GuilleminaultCFaulJLStoohsRSleep-disordered breathing and hypotensionAm J Respir Crit Care Med200116471242124711673217
  • SmitAAHalliwillJRLowPAWielingWPathophysiological basis of orthostatic hypotension in autonomic failureJ Physiol1999519 Pt 111010432334
  • WielingWGroothuisJTPhysiology of upright postureRobertsonDBiaggioniIBurnstockGLowPAPatonJFRPrimer on the Autonomic Nervous System3rd edLondon, UKAcademic Press2012193195
  • FreemanRClinical practice. Neurogenic orthostatic hypotensionN Engl J Med2008358661562418256396
  • VictorRGMarkALInteraction of cardiopulmonary and carotid baroreflex control of vascular resistance in humansJ Clin Invest1985764159215984056042
  • LoavenbruckASandroniPNeurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directionsCurr Med Res Opin201531112095210426373628
  • GibbonsCHSchmidtPBiaggioniIThe recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertensionJ Neurol201726481567158228050656
  • ShawBHClaydonVEThe relationship between orthostatic hypotension and Falling in older adultsClin Auton Res201424131324253897
  • van der MarckMAKlokMPCOkunMSConsensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson’s diseaseParkinsonism Relat Disord201420436036924484618
  • MauleSMilazzoVMauleMMDi StefanoCMilanAVeglioFMortality and prognosis in patients with neurogenic orthostatic hypotensionFunct Neurol201227210110623158582
  • HaADBrownCHYorkMKJankovicJThe prevalence of symptomatic orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonismParkinsonism Relat Disord201117862562821689962
  • MetzlerMDuerrSGranataRKrismerFRobertsonDWenningGKNeurogenic orthostatic hypotension: pathophysiology, evaluation, and managementJ Neurol201326092212221923180176
  • KaufmannHConsensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophyClin Auton Res1996621251268726100
  • SenardJMRaiSLapeyre-MestreMPrevalence of orthostatic hypotension in Parkinson’s diseaseJ Neurol Neurosur Psychiatry1997635584589
  • KöllenspergerMGeserFNdayisabaJPPresentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registryMov Disord201025152604261220922810
  • ThaisetthawatkulPBoeveBFBenarrochEEAutonomic dysfunction in dementia with Lewy bodiesNeurology200462101804180915159482
  • AllanLMBallardCGAllenJAutonomic dysfunction in dementiaJ Neurol Neurosurg Psychiatry200778767167717178816
  • SonnesynHNilsenDWRongveAHigh prevalence of orthostatic hypotension in mild dementiaDement Geriatr Cogn Disord200928430731319828952
  • PodaRGuaraldiPSolieriLStanding worsens cognitive functions in patients with neurogenic orthostatic hypotensionNeurol Sci201233246947321894556
  • PalmaJAGomez-EstebanJCNorcliffe-KaufmannLOrthostatic hypotension in Parkinson disease: how much you fall or how low you go?Mov Disord201530563964525678194
  • RascolOPerez-LloretSDamierPFalls in ambulatory non-demented patients with Parkinson’s diseaseJ Neural Transm (Vienna)2015122101447145525845678
  • BryantMSRintalaDHHouJGProtasEJRelationship of falls and fear of falling to activity limitations and physical inactivity in Parkinson’s diseaseJ Aging Phys Act201523218719324700259
  • VoermansNCSnijdersAHSchoonYBloemBRWhy old people fall (and how to stop them)Pract Neurol20077315817117515595
  • BloemBRvan VugtJPBeckleyDJPostural instability and falls in Parkinson’s diseaseAdv Neurol20018720922311347224
  • FrançoisCHauserRAAballéaSDoreyJKharitonovaEHewittLACost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of phase 3 clinical trial dataJ Med Econ201619551552526710315
  • ShawBHGarlandEMBlackBKOptimal diagnostic thresholds for diagnosis of orthostatic hypotension with a “sit-to-stand test”J Hypertens20173551019102528129252
  • CremerARousseauA-LaureBoulestreauRKuntzSTzourioCGossePScreening for orthostatic hypotension using home blood pressure measurementsJ Hypertens Epub201811910.1097/HJH.0000000000001986
  • CappelleriCJanoschkaABerliRTwenty-four-hour ambulatory blood pressure monitoring in very elderly patients: comparison of in-hospital versus home follow-up resultsMedicine (Baltimore)20179634e769228834872
  • PalmaJAKaufmannHEpidemiology, diagnosis, and management of neurogenic orthostatic hypotensionMov Disord Clin Pract20174329830828713844
  • ShibaoCLipsitzLABiaggioniIAsh position paper: evaluation and treatment of orthostatic hypotensionJ Clin Hypertens (Greenwich)201315314715323458585
  • BiaggioniITreatment: special conditions: orthostatic hypotensionJ Am Soc Hypertens201591676925641107
  • LittleRAKirkmanEDriscollPHansonJMackway-JonesKPreventable deaths after injury: why are the traditional ‘vital’ signs poor indicators of blood loss?J Accid Emerg Med J1995121114
  • SharabiYGoldsteinDSMechanisms of orthostatic hypotension and supine hypertension in Parkinson diseaseJ Neurol Sci20113101–212312821762927
  • ArbiqueDCheekDWelliverMVongpatanasinWManagement of neurogenic orthostatic hypotensionJ Am Med Dir Assoc201415423423924388946
  • FigueroaJJBasfordJRLowPAPreventing and treating orthostatic hypotension: as easy as a, B, CCleve Clin J Med201077529830620439562
  • LahrmannHCortelliPHilzMMathiasCJStruhalWTassinariMEFNS guidelines on the diagnosis and management of orthostatic hypotensionEur J Neurol200613993093616930356
  • NewtonJLFrithJThe efficacy of nonpharmacologic intervention for orthostatic hypotension associated with agingNeurology2018917e652e65630006412
  • Northera® (droxidopa)Full Prescribing InformationDeerfield, ILLundbeck2017
  • ProAmatine® (midodrine hydrochloride)Full Prescribing InformationLexington, MAShire us Inc.2017
  • LoganICWithamMDEfficacy of treatments for orthostatic hypotension: a systematic reviewAge Ageing201241558759422591985
  • IzcovichAGonzález MallaCManzottiMCatalanoHNGuyattGMidodrine for orthostatic hypotension and recurrent reflex syncope: a systematic reviewNeurology201483131170117725150287
  • ParsaikAKSinghBAltayarOMidodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trialsJ Gen Intern Med201328111496150323775146
  • BiaggioniIFreemanRMathiasCJDroxidopa 302 InvestigatorsRandomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopaHypertension201565110110725350981
  • KaufmannHFreemanRBiaggioniIDroxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trialNeurology201483432833524944260
  • HauserRAIsaacsonSLiskJPHewittLARowseGDroxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson’s disease (NOH306B)Mov Disord201530564665425487613
  • HauserRAHeritierSRowseGJHewittLAIsaacsonSHDroxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotensionClin Neuropharmacol201639522022627332626
  • ElgebalyAAbdelazeimBMattarOGadelkarimMSalahRNegidaAMeta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotensionClin Auton Res201626317118026951135
  • KymesSFrançoisCMcLeodKProspective study of real-world outcomes in the treatment of neurogenic orthostatic hypotension with droxidopaNeurology20176616 suppl 1P5.319
  • ChenJJHewittLAComparison of the pharmacokinetics of droxidopa after dosing in the fed versus fasted state and with 3-times-daily dosing in healthy elderly subjectsDrugs R D2018181778629392574
  • ChenJJHanYTangJPortilloIHauserRADashtipourKStanding and supine blood pressure outcomes associated with droxidopa and midodrine in patients with neurogenic orthostatic hypotension: a Bayesian meta-analysis and mixed treatment comparison of randomized trialsAnn Pharmacother201852121182119429972032
  • National Institutes of Health, US National Library of MedicineLabel: fludrocortisone acetate – fludrocortisone acetate tablet Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ed382df-f2d5-46a4-a68b-aba807777093Accessed February 16, 2018
  • EschlböckSWenningGFanciulliAEvidence-based treatment of neurogenic orthostatic hypotension and related symptomsJ Neural Transm (Vienna)2017124121567160529058089
  • MatsubaraSSawaYYokojiHTakamoriMShy-Drager syndrome. Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flowJ Neurol Neurosurg Psychiatry199053119949972283531
  • SchofferKLHendersonRDO’MaleyKO’SullivanJDNonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypo-tension in Parkinson’s diseaseMov Disord200722111543154917557339
  • GrijalvaCGBiaggioniIGriffinMRShibaoCAFludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotensionJ Am Heart Assoc2017610e00684810.1161/JAHA.117.00684829025750
  • SingerWSandroniPOpfer-GehrkingTLPyridostigmine treatment trial in neurogenic orthostatic hypotensionArch Neurol200663451351816476804
  • SenardJMChamontinBRascolAMontastrucJLAmbulatory blood pressure in patients with Parkinson’s disease without and with orthostatic hypotensionClin Auton Res199222991041638111
  • BerganzoKDíez-ArrolaBTijeroBNocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?J Neurol201326071752175623412356
  • TanLCTanAKTjiaHTThe profile of hospitalised patients with Parkinson’s diseaseAnn Acad Med Singapore199827680881210101555
  • WoodfordHWalkerREmergency hospital admissions in idiopathic Parkinson’s diseaseMov Disord20052091104110815884038
  • RudzińskaMBukowczanSStożekJCauses and consequences of falls in Parkinson disease patients in a prospective studyNeurol Neurochir Pol201347542343024166563
  • GarlandEMGamboaAOkamotoLRenal impairment of pure autonomic failureHypertension20095451057106119738158
  • VagaonescuTDSaadiaDTuhrimSPhillipsRAKaufmannHHypertensive cardiovascular damage in patients with primary autonomic failureLancet2000355920572572610703810
  • EspayAJLeWittPAHauserRAMerolaAMasellisMLangAENeurogenic orthostatic hypotension and supine hypertension in Parkinson’s disease and related synucleinopathies: prioritisation of treatment targetsLancet Neurol201615995496627478953
  • BakerJKimpinskiKManagement of supine hypertension complicating neurogenic orthostatic hypotensionCNS Drugs201731865366328702747
  • LowPAPrevalence of orthostatic hypotensionClin Auton Res200818Suppl 181318368301
  • LevyBFritzCTahonEJacquotAAuchetTKimmounAVasoplegia treatments: the past, the present, and the futureCrit Care20182215229486781
  • RobertsonDThe pathophysiology and diagnosis of orthostatic hypotensionClin Auton Res200818Suppl 12718368300